Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Gross Profit | -8,313 | -14,271 | 1,974 | 5,686 | 3,407 |
| Operating Expenses | 0 | 0 | 16,942 | 15,179 | 13,955 |
| Operating Income | N/A | N/A | -16,942 | -15,179 | -13,955 |
| Pre-tax Income | 0 | 0 | -16,942 | -15,179 | -13,955 |
| Net Income Continuous | N/A | N/A | -16,942 | -15,179 | -13,955 |
| Net Income | $N/A | $N/A | $-16,942 | $-15,179 | $-13,955 |
| EBITDA(a) | $1,690 | $1,052 | $-15,889 | $-14,489 | $-12,595 |